Acesion Pharma: Funding, Investors & Team (Sep 2026)
Acesion Pharma is a pharmaceutical company that specializes in creating medical drugs for managing atrial fibrillation. Their drugs target a specific ion channel in heart cells responsible for generating electrical signals that regulate the heart's rhythm. By inhibiting this channel, their treatments aim to prevent the recurrence of AF and maintain a normal heart rhythm, offering long-term relief for patients.
Acesion Pharma has raised $47.6M across 1 funding round on record, the most recent a Series B of $47.6M announced in Sep 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Acesion Pharma Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Acesion Pharma Funding Rounds
Acesion Pharma Founders and Leadership Team
No contact details are on record for this team yet.
Acesion Pharma Funding Compared to Other Biotechnology Startups
Acesion Pharma's latest round of $47.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acesion Pharma in Biotechnology and Copenhagen
Companies Similar to Acesion Pharma
Curasight is a biotech company focused on addressing the need for improved diagnosis and treatment of several…
Alcolase is a Danish life science start-up that specializes in alcohol flushing.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on…
ENZIDIA is unleashing the biomanufacturing revolution with an enzyme acceleration revolution
Gefjon Pharma is a biopharmaceutical company focused on developing innovative solutions to combat…
Synuca Therapeutics focused on developing innovative therapies for neurological disorders, particularly…
Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The…
Pioneering new sustainable bio-based ingredients
Muna Therapeutics is a private biopharmaceutical company that discovers and develops therapies that slow or…
EvodiaBio is a company in the bio-industrial sector that develops eco-friendly fragrances for the food and…
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Chromologics is a company that creates new and original food colorings utilizing natural ingredients. Derived…
Acesion Pharma Funding FAQs
What does Acesion Pharma do?
Acesion Pharma is a pharmaceutical company that specializes in creating medical drugs for managing atrial fibrillation. Their drugs target a specific ion channel in heart cells responsible for generating electrical signals that regulate the heart's rhythm. By inhibiting this channel, their treatments aim to prevent the recurrence of AF and maintain a normal heart rhythm, offering long-term relief for patients.
How much funding has Acesion Pharma raised?
Acesion Pharma has raised $47.6M across 1 round on record. The most recent is a Series B of $47.6M announced in Sep 2023.
When did Acesion Pharma last raise funding?
Acesion Pharma's most recent funding round on record is a Series B of $47.6M, announced in Sep 2023.
Who founded Acesion Pharma?
FundedIQ lists Morten Grunnet (Founder) at Acesion Pharma.
Where is Acesion Pharma headquartered?
Acesion Pharma is based in Copenhagen, Hovedstaden, Denmark.
How many employees does Acesion Pharma have?
Acesion Pharma is in the 11-50 employee band.
How does Acesion Pharma's funding compare to other Biotechnology startups?
Acesion Pharma's latest round of $47.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Acesion Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acesion Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.